Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Brigham and Women's Hospital
With
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
The objective of this study is to test the utility of high sensitivity cardiac troponin (hs-cTn) and coronary artery calcium (CAC) in risk stratifying patients with rheumatoid arthritis (RA) who may benefit from lipid lowering therapy. The population of interest are individuals who would not otherwise be recommended for therapy based on general population risk calculators for heart disease risk.
Age
35–79
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
RA diagnosed by a rheumatologist
Age 40- 79
≥1 ASCVD risk factor including prediabetes, hypertension, BMI \>30, current or history of cigarette smoking
You may not be if
Patients on a statin or with a contraindication to statin, on a cholesterol absorption inhibitor, or on a PCSK9 inhibitor
